Investment Management Corp of Ontario (IMCO)’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.05M Sell
94,823
-11,200
-11% -$608K 0.05% 307
2026
Q1
$6.65M Sell
106,023
-27,518
-21% -$2.2M 0.09% 213
2025
Q4
$12.7M Buy
133,541
+50,494
+61% +$4.95M 0.17% 119
2025
Q3
$8.11M Buy
83,047
+7,549
+10% +$782K 0.12% 134
2025
Q2
$8.11M Sell
75,498
-10,502
-12% -$1.06M 0.12% 116
2025
Q1
$8.68M Buy
+86,000
New +$8.66M 0.18% 92
2024
Q4
Sell
-92,166
Closed -$7.72M 371
2024
Q3
$7.72M Buy
92,166
+16,000
+21% +$1.26M 0.17% 95
2024
Q2
$5.87M Buy
76,166
+52,498
+222% +$3.84M 0.16% 92
2024
Q1
$1.62M Sell
23,668
-10,500
-31% -$675K 0.05% 234
2023
Q4
$1.98M Buy
+34,168
New +$1.82M 0.05% 243
2023
Q3
Sell
-8,726
Closed -$472K 220
2023
Q2
$472K Buy
+8,726
New +$456K 0.02% 176

Other funds holding BSX

Investment Management Corp of Ontario (IMCO)'s BSX Position: Q2 2026 in Review

Investment Management Corp of Ontario (IMCO) reduced its Boston Scientific (BSX) stake by 11% in Q2 2026, selling an estimated $608K and leaving 94,823 shares worth $4.05M. The position accounts for 0.05% of the portfolio, ranked #307.

Investment Management Corp of Ontario (IMCO) first reported a position in BSX in Q2 2023 and has held it in 11 quarters since. The position peaked at $12.7M in Q4 2025. 1,474 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Investment Management Corp of Ontario (IMCO) held 94,823 shares of Boston Scientific worth $4.05M as of Q2 2026.
  • Investment Management Corp of Ontario (IMCO) sold 11,200 Boston Scientific shares in Q2 2026, an estimated $608K.
  • Boston Scientific made up 0.05% of Investment Management Corp of Ontario (IMCO)'s portfolio in Q2 2026, its #307 holding.
  • Investment Management Corp of Ontario (IMCO) first reported a position in Boston Scientific in Q2 2023 and has held it in 11 quarters since.
  • Investment Management Corp of Ontario (IMCO)'s Boston Scientific position peaked at $12.7M in Q4 2025.
  • 1,474 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Investment Management Corp of Ontario (IMCO)'s 13F filing for Q2 2026, filed 14 Aug 2026.